Localized Alveolar Ridge Augmentation With Dental Implant

TerminatedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Alveolar Bone Loss
Interventions
DEVICE

INFUSE® Bone Graft

Patients will be treated with the commercially available INFUSE® Bone Graft material applied to an ACS in the area of the dental implant on Day 0 (Surgery). A follow-up visit will take place 2 weeks after implant of the INFUSE® Bone Graft material, or as regularly scheduled as per the standard of care (SOC) for the facility. Patients will return to the facility for final End of Study (EOS) assessments 6 months after surgery for placement of the appropriate prosthetic, and assessment of osseointegration and stability. Between the follow-up visit and the EOS visit, patients will be seen as per the SOC schedule for the facility.

Trial Locations (6)

28037

Denver

34237

Sarasota

78229

San Antonio

90095

Los Angeles

92350

Loma Linda

97221

Portland

Sponsors
All Listed Sponsors
collaborator

Averion International Corporation

INDUSTRY

lead

Medtronic Spinal and Biologics

INDUSTRY

NCT00991965 - Localized Alveolar Ridge Augmentation With Dental Implant | Biotech Hunter | Biotech Hunter